RIGL Operating Expenses

Rigel Pharmaceuticals Inc · Operating Expenses

RIGL logo

RIGL Operating Expenses

Latest reported$165.90M
RIGL TTM Operating Expenses ($48.73M → $165.90M)
High-resolution chart · PNG

RIGL operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
165,896,000
155,371,000
149,195,000
143,670,000
140,606,000
138,115,000
136,439,000
131,323,000
129,429,000
126,920,000
130,263,000
149,084,000
158,316,000
168,986,000
174,043,000
166,526,000
167,140,000
164,577,000
160,649,000
156,265,000
147,118,000
141,067,000
136,699,000
132,302,000
132,856,000
131,157,000
127,473,000
130,051,000
126,633,000
123,066,000
116,905,000
107,983,000
97,572,000
89,048,000
84,100,000
76,672,000
78,646,000
81,544,000
84,354,000
86,851,000
85,899,000
82,815,000
80,638,000
89,972,000
91,235,000
97,533,000
99,499,000
91,575,000
94,465,000
93,294,000
96,619,000
99,541,000
101,180,000
103,277,000
101,627,000
101,921,000
98,748,000
94,318,000
91,118,000
84,877,000
84,405,000
84,932,000
89,683,000
95,866,000
100,597,000
108,116,000
112,787,000
120,945,000
132,972,000
138,251,000
136,714,000
130,961,000
112,705,000
58,778,000
50,915,000
42,680,000
41,108,000
77,688,000
76,520,000
72,604,000
70,809,000
70,115,000
64,448,000
64,344,000
64,262,000
61,040,000
61,600,000
59,576,000
55,749,000
54,445,000
51,882,000
49,592,000
50,196,000
52,313,000
52,804,000
52,099,000
48,967,000
44,860,000
41,080,000
68,820,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.